Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Saxagliptin (Onglyza) and pioglitazone (Actos) are both medications used to help control blood sugar in people with Type 2 diabetes, but they work in different ways and belong to different drug classes. Saxagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps your body make more insulin by blocking a protein that breaks down hormones involved in insulin production. Pioglitazone, on the other hand, is a thiazolidinedione that improves your body's ability to use insulin. Saxagliptin is taken once daily and is less likely to cause weight gain, while pioglitazone can cause weight gain and fluid build-up. Pioglitazone also has a risk of causing bladder cancer and bone fractures, especially in women, which is not a concern with saxagliptin. Both medications can be taken with or without food, but saxagliptin is available in a generic form, whereas pioglitazone is still available under the brand name Actos.
Saxagliptin (Onglyza)
Pioglitazone (Actos)
Saxagliptin (Onglyza)
Pioglitazone (Actos)
Summary of Onglyza vs. Actos
Summary for DPP-4 inhibitor
Prescription only
Saxagliptin (Onglyza) is an add-on medication to exercise and a balanced, nutritious diet to improve blood sugar control in adults with Type 2 diabetes. It belongs to the drug class called dipeptidyl peptidase-4 (DPP-4) inhibitors. The saxagliptin (Onglyza) dosage is taken by mouth once daily. Possible side effects include certain infections and headaches. The brand name, Onglyza, is no longer available. But the lower-cost generic version is still available.
Summary for Thiazolidinedione
Prescription only
Pioglitazone (Actos) is an oral medication used to treat Type 2 diabetes in adults, along with diet and exercise. It's a thiazolidinedione, which works by helping your body respond better to insulin. This medication is taken by mouth once a day and is available in both brand and generic forms. Side effects include headache, swelling in the body, and weight gain. There's also a serious warning that it can cause or worsen heart failure.